kabutan

Mochida Pharma, 7% Decrease in Ordinary Profit for The Current Fiscal Year

Mon May 12, 2025 2:00 pm JST Earnings

4534 Mochida Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

Mochida Pharmaceutical Co.,Ltd. <4534> [TSE Prime] announced its financial results in the afternoon session on May 12th (14:00). The consolidated ordinary profit for the fiscal year ending March 2025 expanded 33.6% from the previous period to 8.06 billion yen. However, for the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 7.0% from the previous period to 7.5 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit/loss turned to a profit of 0.42 billion yen (compared to a loss of 0.02 billion yen in the same period last year). The operating profit margin significantly improved from 0.0% in the same period last year to 3.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 103,261 8,507 9,085 6,649 178.9 80 May 15, 2023 J-GAAP
Mar, 2024 102,885 5,802 6,037 4,547 126.8 80 May 13, 2024 J-GAAP
Mar, 2025 105,159 8,126 8,067 5,685 160.4 80 May 12, 2025 J-GAAP
YoY +2.2% +40.1% +33.6% +25.0% +26.5%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 106,000 7,500 7,700 5,600 158.0 80 May 13, 2024 J-GAAP
Mar, 2025 Results 105,159 8,126 8,067 5,685 160.4 80 May 12, 2025 J-GAAP
Revision Rate -0.8% +8.3% +4.8% +1.5% +1.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 51,096 3,793 4,079 2,825 79.7 40 Nov 1, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 40 May 12, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 102,885 5,802 6,037 4,547 126.8 80 May 13, 2024 J-GAAP
Mar, 2025 105,159 8,126 8,067 5,685 160.4 80 May 12, 2025 J-GAAP
Mar, 2026 Guidance 110,500 7,000 7,500 5,400 152.3 80 May 12, 2025 J-GAAP
YoY +5.1% -13.9% -7.0% -5.0% -5.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 24,667 11 -22 103 2.9 0.0 May 13, 2024 J-GAAP
Apr - Jun, 2024 25,407 2,189 2,367 1,554 43.9 8.6 Aug 2, 2024 J-GAAP
Jul - Sep, 2024 25,689 1,604 1,712 1,271 35.9 6.2 Nov 1, 2024 J-GAAP
Oct - Dec, 2024 29,635 3,450 3,561 2,780 78.4 11.6 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 24,428 883 427 80 2.3 3.6 May 12, 2025 J-GAAP
YoY -1.0% +7,927.3% － -22.3% -21.3%

Related Articles